Market Cap | 9.24B | P/E | 40.55 | EPS this Y | 32.20% | Ern Qtrly Grth | 41.50% |
Income | 163.5M | Forward P/E | 50.85 | EPS next Y | 18.10% | 50D Avg Chg | -10.00% |
Sales | 787.97M | PEG | 2.63 | EPS past 5Y | - | 200D Avg Chg | 4.00% |
Dividend | N/A | Price/Book | 16.17 | EPS next 5Y | 25.00% | 52W High Chg | -21.00% |
Recommedations | 3.00 | Quick Ratio | 12.50 | Shares Outstanding | 37.54M | 52W Low Chg | 46.00% |
Insider Own | 1.20% | ROA | 8.68% | Shares Float | 37.48M | Beta | 0.88 |
Inst Own | 98.73% | ROE | 24.73% | Shares Shorted/Prior | 1.83M/1.47M | Price | 252.23 |
Gross Margin | 86.99% | Profit Margin | 20.75% | Avg. Volume | 563,770 | Target Price | 324.27 |
Oper. Margin | 19.38% | Earnings Date | Aug 5 | Volume | 408,157 | Change | -2.90% |
Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California. As of May 31, 2024, Shockwave Medical, Inc. operates as a subsidiary of Johnson & Johnson.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
PUCKETT DAN | Chief Financial Offi.. Chief Financial Officer | Feb 05 | Sell | 230.7 | 3,229 | 744,930 | 21,005 | 02/06/24 |
PUCKETT DAN | Chief Financial Offi.. Chief Financial Officer | Feb 01 | Sell | 229.92 | 3,406 | 783,108 | 27,732 | 02/02/24 |
Zacharias Isaac | President, CCO President, CCO | Jan 26 | Sell | 224.69 | 4,000 | 898,760 | 63,920 | 01/29/24 |
Zacharias Isaac | President, CCO President, CCO | Jan 26 | Option | 6.71 | 4,000 | 26,840 | 67,920 | 01/29/24 |
Godshall Douglas Evan | President & CEO President & CEO | Jan 16 | Sell | 217.93 | 10,000 | 2,179,300 | 141,057 | 01/18/24 |
Godshall Douglas Evan | President & CEO President & CEO | Jan 16 | Option | 3.42 | 10,000 | 34,200 | 151,057 | 01/18/24 |
Zacharias Isaac | President, CCO President, CCO | Jan 12 | Option | 5.37 | 17,921 | 96,236 | 63,920 | 01/17/24 |
WATKINS FRANK T | Director Director | Jan 08 | Sell | 198.09 | 2,000 | 396,180 | 4,532 | 01/10/24 |
WATKINS FRANK T | Director Director | Jan 08 | Option | 3.42 | 2,000 | 6,840 | 6,532 | 01/10/24 |
Godshall Douglas Evan | President & CEO President & CEO | Jan 05 | Sell | 200.05 | 10,000 | 2,000,500 | 141,057 | 01/08/24 |
Godshall Douglas Evan | President & CEO President & CEO | Jan 05 | Option | 3.42 | 10,000 | 34,200 | 151,057 | 01/08/24 |
WATKINS FRANK T | Director Director | Jun 20 | Option | 3.416 | 3,000 | 10,248 | 4,532 | 01/04/24 |
Zacharias Isaac | President, CCO President, CCO | Dec 26 | Sell | 192.5 | 4,000 | 770,000 | 41,606 | 12/28/23 |
Zacharias Isaac | President, CCO President, CCO | Dec 26 | Option | 6.71 | 3,458 | 23,203 | 45,606 | 12/28/23 |
Godshall Douglas Evan | President & CEO President & CEO | Dec 15 | Sell | 188.79 | 5,000 | 943,950 | 141,057 | 12/18/23 |
Godshall Douglas Evan | President & CEO President & CEO | Dec 15 | Option | 3.42 | 5,000 | 17,100 | 146,057 | 12/18/23 |
PUCKETT DAN | Chief Financial Offi.. Chief Financial Officer | Dec 08 | Sell | 173.88 | 200 | 34,776 | 28,784 | 12/11/23 |
Phung Trinh | VP, Finance VP, Finance | Dec 07 | Sell | 171.63 | 203 | 34,841 | 29,037 | 12/08/23 |
Zacharias Isaac | President, CCO President, CCO | Nov 27 | Sell | 173.58 | 4,000 | 694,320 | 43,868 | 11/28/23 |
Zacharias Isaac | President, CCO President, CCO | Nov 27 | Option | 6.71 | 3,777 | 25,344 | 47,868 | 11/28/23 |
WATKINS FRANK T | Director Director | Nov 20 | Sell | 173.11 | 3,000 | 519,330 | 1,532 | 11/21/23 |
WATKINS FRANK T | Director Director | Nov 20 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 11/21/23 |
Godshall Douglas Evan | President & CEO President & CEO | Nov 15 | Sell | 174.38 | 5,000 | 871,900 | 136,057 | 11/17/23 |
Godshall Douglas Evan | President & CEO President & CEO | Nov 15 | Option | 3.42 | 5,000 | 17,100 | 141,057 | 11/17/23 |
Phung Trinh | VP, Finance VP, Finance | Apr 26 | Option | 3.42 | 2,400 | 8,208 | 31,095 | 11/03/23 |
Zacharias Isaac | President, CCO President, CCO | Oct 26 | Sell | 210.25 | 4,000 | 841,000 | 44,316 | 10/30/23 |
Zacharias Isaac | President, CCO President, CCO | Oct 26 | Option | 6.71 | 411 | 2,758 | 48,316 | 10/30/23 |
WATKINS FRANK T | Director Director | Oct 20 | Sell | 203.14 | 3,000 | 609,420 | 1,532 | 10/23/23 |
WATKINS FRANK T | Director Director | Oct 20 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 10/23/23 |
Godshall Douglas Evan | President & CEO President & CEO | Oct 16 | Sell | 199.71 | 10,000 | 1,997,100 | 141,649 | 10/17/23 |
Godshall Douglas Evan | President & CEO President & CEO | Oct 16 | Option | 3.42 | 10,000 | 34,200 | 151,649 | 10/17/23 |
Zacharias Isaac | President, CCO President, CCO | Sep 26 | Sell | 192.12 | 4,000 | 768,480 | 47,905 | 09/27/23 |
WATKINS FRANK T | Director Director | Sep 20 | Sell | 209.23 | 3,000 | 627,690 | 1,532 | 09/21/23 |
WATKINS FRANK T | Director Director | Sep 20 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 09/21/23 |
Godshall Douglas Evan | President & CEO President & CEO | Sep 15 | Sell | 212.62 | 10,000 | 2,126,200 | 141,649 | 09/19/23 |
Godshall Douglas Evan | President & CEO President & CEO | Sep 15 | Option | 3.42 | 10,000 | 34,200 | 151,649 | 09/19/23 |
Phung Trinh | VP, Finance VP, Finance | Aug 29 | Option | 3.416 | 5,000 | 17,080 | 25,986 | 08/31/23 |
Zacharias Isaac | President, CCO President, CCO | Aug 25 | Sell | 204.98 | 4,000 | 819,920 | 52,446 | 08/29/23 |
Godshall Douglas Evan | President & CEO President & CEO | Aug 24 | Sell | 212.95 | 10,000 | 2,129,500 | 141,649 | 08/25/23 |
Godshall Douglas Evan | President & CEO President & CEO | Aug 24 | Option | 3.42 | 10,000 | 34,200 | 151,649 | 08/25/23 |
FRANCIS LAURA | Director Director | Aug 22 | Sell | 220.97 | 497 | 109,822 | 3,054 | 08/23/23 |
WATKINS FRANK T | Director Director | Aug 21 | Sell | 218.97 | 3,000 | 656,910 | 1,532 | 08/22/23 |
WATKINS FRANK T | Director Director | Aug 21 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 08/22/23 |
Toyloy Sara | Director Director | Aug 15 | Sell | 223.64 | 100 | 22,364 | 3,673 | 08/16/23 |
Zacharias Isaac | President, CCO President, CCO | Jul 26 | Sell | 268.06 | 4,000 | 1,072,240 | 56,678 | 07/27/23 |
WATKINS FRANK T | Director Director | Jul 20 | Sell | 267.11 | 3,000 | 801,330 | 1,532 | 07/21/23 |
WATKINS FRANK T | Director Director | Jul 20 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 07/21/23 |
Papiernik Antoine | Director Director | Jul 05 | Option | 17.00 | 17,381 | 295,477 | 22,662 | 07/06/23 |
Zacharias Isaac | President, CCO President, CCO | Jun 26 | Sell | 291.84 | 4,000 | 1,167,360 | 60,678 | 06/26/23 |
Phung Trinh | VP, Finance VP, Finance | Jun 22 | Sell | 295.91 | 62 | 18,346 | 21,101 | 06/26/23 |